• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ2100673 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs License Renew 2021-10-28 view
JYHZ2100672 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs License Renew 2021-10-28 view
JYHZ2100671 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs License Renew 2021-10-28 view
JYHZ2100670 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs License Renew 2021-10-28 view
JYHF1900121 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2019-08-10 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd Certificate Issued 2019-09-04 view
JYHF1800006 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2018-01-26 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd Certificate Issued 2018-02-28 view
JYHF1800005 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2018-01-26 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd Certificate Issued 2018-02-28 view
JYHB2300103 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2023-02-08 view
JYHB2300102 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2023-02-08 view
JYHB2300101 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2023-02-08 view
JYHB2300100 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2023-02-08 view
JYHB2001377 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2020-08-21 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd Filed 2020-09-02 view
JYHB2001376 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2020-08-21 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd Filed 2020-09-02 view
JYHB1801111 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2018-09-18 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd Filed 2018-09-20 view
JYHB1801110 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2018-09-18 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd Filed 2018-09-20 view
JYHB1801109 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2018-09-18 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd Filed 2018-09-20 view
JYHB1801108 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2018-09-18 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd Filed 2018-09-20 view
JYHB1701348 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2017-10-28 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd Certificate Issued 2017-12-26 view
JYHB1701347 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2017-10-31 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd Certificate Issued 2017-12-21 view
JYHB1701346 米拉贝隆缓释片 mirabegron Tablet, extended release Chemical Drugs Supplementary Application 2017-10-28 安斯泰来制药(中国)有限公司 Astellas Pharmaceutical (China) Co Ltd Certificate Issued 2017-12-26 view